- Home
- TAOP vs ENVB Comparison
TAOP vs ENVB Comparison
Compare TAOP & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAOP
- ENVB
- Stock Information
- Founded
- TAOP 1993
- ENVB 1994
- Country
- TAOP China
- ENVB United States
- Employees
- TAOP N/A
- ENVB N/A
- Industry
- TAOP Computer Software: Prepackaged Software
- ENVB Biotechnology: Pharmaceutical Preparations
- Sector
- TAOP Technology
- ENVB Health Care
- Exchange
- TAOP Nasdaq
- ENVB Nasdaq
- Market Cap
- TAOP 2.9M
- ENVB 3.0M
- IPO Year
- TAOP N/A
- ENVB N/A
- Fundamental
- Price
- TAOP $2.26
- ENVB $5.22
- Analyst Decision
- TAOP
- ENVB Strong Buy
- Analyst Count
- TAOP 0
- ENVB 1
- Target Price
- TAOP N/A
- ENVB $120.00
- AVG Volume (30 Days)
- TAOP 46.5K
- ENVB 126.7K
- Earning Date
- TAOP 12-08-2025
- ENVB 11-14-2025
- Dividend Yield
- TAOP N/A
- ENVB N/A
- EPS Growth
- TAOP N/A
- ENVB N/A
- EPS
- TAOP N/A
- ENVB N/A
- Revenue
- TAOP $36,196,786.00
- ENVB N/A
- Revenue This Year
- TAOP N/A
- ENVB N/A
- Revenue Next Year
- TAOP N/A
- ENVB N/A
- P/E Ratio
- TAOP N/A
- ENVB N/A
- Revenue Growth
- TAOP N/A
- ENVB N/A
- 52 Week Low
- TAOP $1.81
- ENVB $5.20
- 52 Week High
- TAOP $24.75
- ENVB $96.30
- Technical
- Relative Strength Index (RSI)
- TAOP 36.30
- ENVB 58.10
- Support Level
- TAOP $2.18
- ENVB $5.52
- Resistance Level
- TAOP $2.45
- ENVB $6.10
- Average True Range (ATR)
- TAOP 0.16
- ENVB 0.89
- MACD
- TAOP 0.00
- ENVB -0.10
- Stochastic Oscillator
- TAOP 12.50
- ENVB 2.93
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.